GTCR-backed Corza Medical to sell its biosurgery business unit to EQT

Also included in the sale is the TachoSil product portfolio.

7 July 2026•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.